glp1medication.guide

natural

OMAD (One Meal a Day): The Evidence, Including the Bits People Skip

What this page establishes

  • Krista Varady, who has studied intermittent fasting for two decades, states there is not enough evidence to know whether one meal a day is safe or effective, and that well-controlled clinical trials of OMAD are lacking.
  • Muscle-protein-synthesis research supports spreading protein across meals, which makes hitting a 1.2-1.6 g/kg/day protein target in a single sitting the practical failure point of OMAD during a deficit.

Quick answers

  • How much weight will I lose on OMAD?

    It depends entirely on the size of the calorie gap it creates, not on the schedule. People commonly land in a very large deficit without intending to, which is why the scale moves fast and why lean-mass loss is a real risk at the same time.

  • Does OMAD raise cholesterol?

    A controlled study of evening one-meal-a-day eating found fasting LDL-cholesterol increased on that pattern.

    Read the full answer
    If you run OMAD beyond a few weeks, get a lipid panel rather than assuming it does not apply to you.
  • Can I hit my protein target in one meal?

    Most people cannot comfortably. For an 85 kg adult the target is roughly 100-135 g, and that is a large volume to eat in one sitting alongside everything else.

    Read the full answer
    This is the single biggest reason OMAD costs muscle.

OMAD produces weight loss for an unglamorous reason: eating a full day of maintenance calories in one sitting is difficult, so most people who try it end up in a large deficit by accident. The schedule is not doing anything metabolically clever. What makes OMAD worth its own page is the asymmetry between how confidently it is promoted and how little controlled evidence exists for it, plus two findings that rarely appear in the promotion.

What OMAD is, and how 23:1 differs from 16:8

OMAD compresses all intake into roughly a one-hour eating window each day. In the taxonomy of time-restricted eating it is the extreme end of the same axis as 16:8, and the difference between them is not a matter of degree in practice. An eight-hour window still allows two or three eating occasions and a normal protein distribution. A one-hour window allows one of each.

The mechanism is calorie restriction. That deserves stating plainly on this page in particular, because OMAD attracts more metabolic folklore than any other protocol here. There is no fat-burning state that a second meal interrupts. There is a very large deficit created by physically limiting how much food fits in a single sitting.

What the controlled data actually covers

Very little. Krista Varady, who has studied intermittent fasting for two decades, states there is not enough evidence to know whether one meal a day is safe or effective, and that well-controlled clinical trials of OMAD are lacking. That is the position of one of the field's most productive researchers, not a sceptic outside it.

The major fasting meta-analyses cover alternate-day fasting, whole-day protocols like 5:2, and time-restricted eating with windows of four hours and up. OMAD sits at the edge of that literature rather than inside it. When you see a weekly-rate figure for OMAD, including the 0.3-1.0% range this site publishes, understand that it is an inference from how large the deficit tends to be, not a result read off a trial.

This is the weakest evidence base in the cluster OMAD has the highest published rate range and the thinnest support for it. Those two facts belong together. A high number derived from a mechanism rather than a trial is not the same kind of number as the 5:2 or 16:8 figures.

The LDL and fasting-glucose findings

In a controlled study of one-meal-per-day eating in the evening in lean individuals, fasting plasma LDL-cholesterol concentrations rose on the one-meal-a-day pattern. That is a cardiovascular risk marker moving in the wrong direction while the scale moves in the right one.

Reported effects of eating one meal per day rather than three also include higher fasting blood sugar, a delayed insulin response, and increased ghrelin. These come from secondary summaries of controlled feeding work, so treat the direction as more reliable than the magnitude.

The practical response is not to panic, it is to measure. If you run OMAD for more than a few weeks, get a lipid panel and a fasting glucose. You cannot feel LDL.

Protein is the structural problem

During a deficit, a protein intake of 1.2-1.6 g/kg/day supports lean-mass retention, and muscle-protein-synthesis research favours spreading that intake across meals rather than concentrating it. OMAD does the opposite by design.

Run the arithmetic for an 85 kg adult. The target is roughly 100-135 g of protein. In one sitting, that is around 500 g of cooked chicken breast, or a comparable volume from any other source, eaten alongside everything else you plan to eat that day. Most people cannot, and most people do not.

That is why OMAD carries the highest lean-mass risk of any protocol in this cluster. The weight comes off quickly and a larger share of it than you want is muscle. Resistance training helps and does not fully compensate for a protein intake that keeps landing at 60 g.

Hunger hormones and the rebound

Increased ghrelin is among the reported effects of the one-meal pattern. Ghrelin is the signal that makes you seek food, and elevated ghrelin against a schedule that forbids eating is a fight you have to win daily.

This is why the adherence dropoff on OMAD is high. The protocol is simple and the pressure is constant, and the failure tends to be abrupt rather than gradual. People do not drift off OMAD, they abandon it in a single evening.

Who should not do OMAD

The contraindication list here is longer than for gentler protocols, because the intake swing is larger.

If restriction is already loaded for you Fasting schedules can escalate disordered eating fast, and the risk rises with how aggressive the protocol is. In the US, the National Alliance for Eating Disorders helpline is 1-866-662-1235. In the UK, Beat runs a helpline on 0808 801 0677. Talking to someone is a better first step than a stricter protocol.

A safer version, if the simplicity is what you want

Most of what people like about OMAD is the absence of decisions. You can get that without a 23-hour window.

Two meals inside a six to eight hour window keeps the decision-free quality, allows protein to be split across two feedings, and puts you in the part of the literature that actually has controlled trials behind it. The measured weight-loss difference between that and OMAD is not established, because OMAD has not been measured properly. What is established is that the protein distribution is better and the LDL finding does not attach to it.

The evidence, one row per claim

ClaimTierSource
In a controlled study of one-meal-per-day eating in the evening in lean individuals, fasting plasma LDL-cholesterol concentrations increased on the one-meal-a-day pattern.emergingFrontiers in Physiology — one meal per day in the evening
Krista Varady, who has studied intermittent fasting for two decades, states there is not enough evidence to know whether one meal a day is safe or effective, and that well-controlled clinical trials of OMAD are lacking.establishedUS News (quoting Varady, UIC)
Reported effects of eating one meal per day versus three include higher fasting blood sugar, a delayed insulin response, and increased ghrelin.emergingHealthline review (secondary; trace to the Stote et al. controlled feeding study before publishing)
Muscle-protein-synthesis research supports spreading protein across meals, which makes hitting a 1.2-1.6 g/kg/day protein target in a single sitting the practical failure point of OMAD during a deficit.establishedClin Nutr ESPEN — enhanced protein intake and muscle mass meta-analysis

Questions people ask

Is OMAD better than 16:8?
There is no trial that answers that properly, which is itself the answer. 16:8 has meta-analytic support and low dropout. OMAD has a larger typical deficit, a much weaker evidence base, and a worse protein profile.

Sources

  1. Frontiers in Physiology — one meal per day in the evening
  2. US News (quoting Varady, UIC)
  3. Healthline review (secondary; trace to the Stote et al. controlled feeding study before publishing)
  4. Clin Nutr ESPEN — enhanced protein intake and muscle mass meta-analysis

Where this comes from

Every number on this page traces to a named source. There are 4 sourced claims below the fold, each with the document it came from.

Sources consulted: Frontiers in Physiology — one meal per day in the evening, US News, Healthline review, Clin Nutr ESPEN — enhanced protein intake and muscle mass meta-analysis.

Not clinically reviewed. This page was researched and written against primary regulatory and trial sources, and no clinician has checked it.

Sources last read 2026-08-23.

Keep reading

Educational content, reviewed 2026-08-23. Not medical advice, not a prescription, and not a substitute for a clinician who knows your history. Doses named here are label schedules or doses used in named trials, never a recommendation to you.

Evidence updates

When a number here changes, you will know